INFLUENCE OF AKT1, AKT2 AND FRAP1 POLYMORPHISMS ON RESPONSE AND SURVIVAL IN HEAD AND NECK CANCER (SCCHN) PATIENTS TREATED WITH DOCETAXEL AND CETUXIMAB

被引：0
|
作者：
Pfisterer, K. [1 ]
Klinghammer, K. [1 ]
Fusi, A. [1 ]
Knoedler, M. [1 ]
Nonnenmacher, A. [1 ]
Keilholz, U. [1 ]
机构：
[1] Charite CBF, Berlin, Germany
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：316 / 316
页数：1
相关论文
共 50 条
  • [31] AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins
    Riggio, Marina
    Perrone, Maria C.
    Polo, Maria L.
    Rodriguez, Maria J.
    May, Maria
    Abba, Martin
    Lanari, Claudia
    Novaro, Virginia
    SCIENTIFIC REPORTS, 2017, 7
  • [32] Akt1 and Akt3 but not Akt2 through interaction with DNA-PKcs stimulate proliferation and post-irradiation cell survival of K-RAS-mutated cancer cells
    Mahmoud Toulany
    Julia Maier
    Mari Iida
    Simone Rebholz
    Marina Holler
    Astrid Grottke
    Manfred Jüker
    Deric L Wheeler
    Ulrich Rothbauer
    H Peter Rodemann
    Cell Death Discovery, 3
  • [33] The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab
    T Magnes
    T Melchardt
    C Hufnagl
    L Weiss
    C Mittermair
    D Neureiter
    E Klieser
    G Rinnerthaler
    S Roesch
    A Gaggl
    R Greil
    A Egle
    The Pharmacogenomics Journal, 2018, 18 : 474 - 479
  • [34] Akt1 and Akt3 but not Akt2 through interaction with DNA-PKcs stimulate proliferation and post-irradiation cell survival of K-RAS-mutated cancer cells
    Toulany, Mahmoud
    Maier, Julia
    Lida, Mad
    Rebholz, Simone
    Holler, Marina
    Grottke, Astrid
    Jueker, Manfred
    Wheelers, Deric L.
    Rothbauer, Ulrich
    Rodemann, H. Peter
    CELL DEATH DISCOVERY, 2017, 3
  • [35] The Influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab
    Magnes, T.
    Melchardt, T.
    Hufnagl, C.
    Weiss, L.
    Mittermair, C.
    Neureiter, D.
    Klieser, E.
    Rinnerthaler, G.
    Roesch, S.
    Gaggl, A.
    Greil, R.
    Egle, A.
    PHARMACOGENOMICS JOURNAL, 2018, 18 (03): : 474 - 479
  • [36] Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab
    T. Magnes
    T. Melchardt
    C. Hufnagl
    L. Weiss
    C. Mittermair
    D. Neureiter
    E. Klieser
    G. Rinnerthaler
    S. Roesch
    A. Gaggl
    R. Greil
    A. Egle
    The Pharmacogenomics Journal, 2020, 20 : 350 - 350
  • [37] Immuno-Matrix-Assisted Laser Desorption/Ionization Assays for Quantifying AKT1 and AKT2 in Breast and Colorectal Cancer Cell Lines and Tumors
    Popp, Robert
    Li, Huiyan
    LeBlanc, Andre
    Mohammed, Yassene
    Aguilar-Mahecha, Adriana
    Chambers, Andrew G.
    Lan, Cathy
    Poetz, Oliver
    Basik, Mark
    Batist, Gerald
    Borchers, Christoph H.
    ANALYTICAL CHEMISTRY, 2017, 89 (19) : 10592 - 10600
  • [38] Association of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinib
    Zucali, Paolo A.
    Giovannetti, Elisa
    Peters, Godefridus
    Cortesi, Filippo
    D'Incecco, Armida
    Smit, Egbert
    Falcone, Alfredo
    Burgers, Sjaak
    Santoro, Armando
    Danesi, Romano
    Giaccone, Giuseppe
    Tibaldi, Carmelo
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S510 - S510
  • [39] Association of Polymorphisms in AKT1 and EGFR with Clinical Outcome and Toxicity in Non-Small Cell Lung Cancer Patients Treated with Gefitinib
    Giovannetti, Elisa
    Zucali, Paolo A.
    Peters, Godefridus J.
    Cortesi, Filippo
    D'Incecco, Armida
    Smit, Egbert F.
    Falcone, Alfredo
    Burgers, Jacobus A.
    Santoro, Armando
    Danesi, Romano
    Giaccone, Giuseppe
    Tibaldi, Carmelo
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (03) : 581 - 593
  • [40] SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes
    Sasaoka, T
    Wada, T
    Fukui, K
    Murakami, S
    Ishihara, H
    Suzuki, R
    Tobe, K
    Kadowaki, T
    Kobayashi, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (15) : 14835 - 14843
12345